Skip to main content

Editorial message from Editor-in-Chief

It is my great honor to announce the birth of Acta Epileptologica, a new open access, peer-reviewed journal of the China Association Against Epilepsy(CAAE).

 Acta Epileptologica will rapidly publish robust and high-quality results that provide insights into all aspects of epilepsy research, covering basic, translational and clinical research in epilepsy. Submissions of high-quality research on the mechanisms of epileptogenesis, broader comorbidities of epilepsy, new treatments and their measures are especially welcome. Acta Epileptologica also publishes communications and guidelines from the CAAE. This new journal is to serve as a unique forum committed to facilitating basic and clinical epilepsy research by providing trustworthy and speedy publishing service.

We hope this new journal will further stimulate the individualized treatment of epilepsy and provide evidence-based medical advice to doctors in rural areas and less developed countries at the same time. We have assembled a strong editorial team with outstanding epileptic experts worldwide, and we will keep strengthening it in terms of academic authority, specialty balance and epileptic scope. On behalf of the journal editorial committee, I promise to provide the authors unbiased, constructive, and timely peer reviews to help disseminate their research findings expeditiously and broadly; to present the readers with original, high-quality research papers to facilitate them to keep pace with the latest developments in the related areas of epilepsy.

 We are confident to establish Acta Epileptologica as a reputable forum for the international epilepsy community.

 Your manuscript and feedback are most welcome!

 Thank you for your warm support to Acta Epileptologica.


Editor-in-Chief of Acta Epileptologica

Call for paper: Virus and Epilepsy

Acta Epileptologica invites you to submit the manuscript with the topic: Virus and Epilepsy to share with the knowledge and points about the one of the important and common pathogenies of epilepsy. Especially welcome manuscripts on novel coronavirus and epilepsy. The editorial office is dedicated to process the submissions with highly priority.

The recommending themes: 
1. The introduce of Pathogenesis, Host, Pathogenicity, Clinical Characteristics, Treatment, Prognosis about virus which induce or enhance the seizure. 
2. The new finding about the pathogenic mechanism by virus related to epileptogenesis.
3. The new drugs to treat the virus or prevent the epileptogenesis. 
4. Drug interaction of the antiviral’s treatment and the antiepileptic drugs.
5. The hospital or home management of the patient after virus infecting and the epilepsy.
6. Short term and long-term prognosis of epilepsy after the virus infection.
Deadline for submission:  December 31, 2020 

Welcome to submit!

Journal Announcement

Acta Epileptologica is now officially indexed in Directory of Open Access Journals (DOAJ)!

Welcome to visit!

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Aims and scope

Acta Epileptologica is dedicated to advancing people’s understanding of epilepsy by providing a forum to share the latest research. The main focus of the journal covers all aspects related to epilepsy, topics include but are not limited to basic research, practical management of epilepsy, neuroimaging, therapeutic trials, case report, social and psychological burden. In addition to the mechanisms of epileptogenesis, broader comorbidities of epilepsy, new treatments and their measures.

2020 New Year Message

New Content Item

2020 New Year Greetings from Editor-in-Chief of Acta Epileptologica

About the Editor

Professor Shichuo Li 

Professor Li is the Founding President of the China Association Against Epilepsy (CAAE). He is also Advisor for Public Health of ILAE Executive Committee and the Co-chairmen of the ILAE/IBE Global Outreach Taskforce.

Professor Li was formerly the Assistant Director-General of the World Health Organization (WHO), WHO Representative of South Pacific (1998 - 2003), the Director-General of the Department of International Cooperation at the Ministry of Health, China (1992 - 1997)and the Vice Director of the Beijing Municipal Health Bureau (1987 - 1992).

In the 1980s, Prof. Li worked at the National Institutes of Health (NIH) at Bethesda, Maryland, USA as a visiting scientist for 2 years. Over the past years, besides all the administrative and International cooperation activities, Prof. Li has also dedicated himself to the epidemiology research of neurological diseases as well as the prevention and control of cerebrovascular diseases and epilepsy in the community.  His research has gained more than 10 Beijing municipal and National science development awards.

Professor Li has published extensively with more than 70 articles in China as well as internationally.  As a chief editor, he has also published a book entitled ‘Epidemiology of Nervous System Diseases” and a “Green Book of Prevention and Control of Epilepsy in China”.

Official journal of

Annual Journal Metrics

  • Speed
    72 days to first decision for reviewed manuscripts only
    63 days to first decision for all manuscripts
    127 days from submission to acceptance
    46 days from acceptance to publication